X0306 4 2023-03-12 0001531048 Inari Medical, Inc. NARI 0001644989 Hill, Mitch C. C/O INARI MEDICAL, INC. 6001 OAK CANYON IRVINE CA 92618 1 Chief Financial Officer Common Stock 2023-03-12 4 M 0 125393 0 A 193285 D Common Stock 2023-03-13 4 M 0 6500 .457 A 199785 D Common Stock 2023-03-13 4 S 0 600 56.86 D 199185 D Common Stock 2023-03-13 4 S 0 1300 58.07 D 197885 D Common Stock 2023-03-13 4 S 0 4600 59.02 D 193285 D Common Stock 2023-03-13 4 S 0 600 56.90 D 192685 D Common Stock 2023-03-13 4 S 0 1700 58.27 D 190985 D Common Stock 2023-03-13 4 S 0 3950 59.06 D 187035 D Common Stock 1600 I By Spouse Restricted Stock Unit 0 2023-03-12 4 M 0 125393 0 D Common Stock 125393 0 D Stock Options (Right to Buy) .457 2023-03-13 4 M 0 6500 0 D 2029-04-23 Common Stock 6500 152977 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022. This transaction was executed in multiple trades at prices ranging from $56.54 to $57.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $57.55 to $58.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $58.58 to $59.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $56.54 to $57.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $57.66 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $58.66 to $59.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied. Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter. /s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill 2023-03-14